Here are relevant reports on : clinical-trials-recruitment-market
-
Healthcare Middleware Market by Type (Communication (RPC, Message Oriented Middleware), Platform (Web, Portal, Database), Integration, ESB, BPM, BAM), Application (Clinical), Deployments Model (On-premise, Cloud), End User - Global Forecast to 2023
The global healthcare middleware market is expected to reach USD 3.07 Billion by 2023 from USD 1.90 Billion in 2018, at a CAGR of 10.0%. Increasing utilization of smart devices, the availability of big data in healthcare, increasing need for data interoperability, and growing investments to overcome healthcare interoperability issues are the key drivers of the global healthcare middleware market. The healthcare middleware market is highly fragmented with the presence of several large as well as emerging players. Prominent players in the healthcare middleware market include Corepoint Health (US), Cerner Corporation (US), Epic Systems Corporation (US), Fujitsu (Japan), IBM Corporation (US), InterSystems Corporation (US), Oracle Corporation (US), Microsoft Corporation (US), Orion Health (New Zealand), Red Hat (US), Software AG (Germany), TIBCO Software (US), Ascom (Switzerland), Informatica (US), and Zoeticx, Inc. (US).
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
Animal Protein Ingredients Market By Type (Dairy, Egg, Gelatin), Application (Dairy, Clinical Nutrition, Dietetic & Sports Food, Confectionery, Beverages, Meat, Bakery), By Geography: Trends & Forecasts To 2018
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
US Artificial Intelligence (AI) in Healthcare Market by Offering (Integrated), Function (Diagnosis, Genomic, Precision Medicine, Radiation, Telehealth, Immunotherapy, Pharmacy, Supply Chain), Application (Clinical), End User (Hospitals) - Forecast to 2030
The US artificial intelligence (AI) in healthcare market, valued at US$5.98 billion in 2024, stood at US$8.65 billion in 2025 and is projected to advance at a resilient CAGR of 38.0% from 2025 to 2030, culminating in a forecasted valuation of US$43.30 billion by the end of the period. Market growth is driven by rising demand from providers for automation, nationwide labor shortages, increasing clinical complexity, and strong investment in predictive analytics, imaging AI, and GenAI.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Veterinary Reference Laboratory Market by Service (Microbiology, Immunodiagnostics, Molecular Diagnostics, PCR, ELISA, Hematology, Urinalysis), Animal (Companion, Livestock), Application (Clinical Pathology, Toxicology), Region - Global Forecast to 2030
The global veterinary reference laboratory market, valued at US$4.48 billion in 2024, stood at US$4.75 billion in 2025 and is projected to advance at a resilient CAGR of 6.3% from 2024 to 2030, culminating in a forecasted valuation of US$6.45 billion by the end of the period.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Asia Pacific Proteomics Market by Instrumentation [Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray], Reagent (Immunoassay), Service (Purification, Bioinformatics), Software, Application (Clinical, Drug Discovery) - Forecast to 2030
The Asia Pacific Proteomics Market, valued at USD 7.82 billion in 2024, stood at USD 8.57 billion in 2025 and is projected to advance at a resilient CAGR of 14.1% from 2025 to 2030, culminating in a forecasted valuation of USD 16.61 billion by the end of the period. Proteomics focuses on measuring dynamic protein expression, modifications, and interactions at scale, enabling deeper insights into disease biology and treatment response for oncology, neurology, and other complex indications.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Healthcare IoT Market by Usage (Embedded System, Wireless Network), Product (Monitoring & Notification System, Software), End User (Hospital, Academia, Government), Application (Telemedicine, Clinical Trial, Asset Management)- Global Forecasts to 2019
Emerging markets including Middle East, China, India, Mexico, and Brazil have become attractive destinations for companies engaged in the development and distribution of healthcare IoT products. A number of factors such as growing adoption of cloud-based and mobile healthcare technologies in emerging countries, rising medical tourism due to low cost healthcare facilities, and expansion of healthcare infrastructure across emerging countries (especially in rural areas) are offering high growth opportunities for players active in the global healthcare IoT market.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Antinuclear Antibody Test Market by Product (Reagents & Assay Kits, Systems, Software, Services), Technique (Immunofluorescence, Elisa, Multiplex), Disease (Rheumatoid Arthritis, SLE), End User (Clinical Labs, Hospitals) - Global Forecast to 2021
The global antinuclear antibody test market size is projected to grow at a CAGR of 12.4%. This market is segmented based on products, diseases, techniques, end users, and regions. On the basis of products, the ANA testing market is segmented into assay kits & reagents, systems, and software & services. The assay kits & reagents segment is expected to account for the largest share of the global ANA testing market, primarily due to the growing number of reagent rental agreements and increasing prevalence of autoimmune diseases worldwide.
- Published: September 2016
- Price: $ 4950
- TOC Available:
-
Hematology Testing Market byTest [CBC (Hemoglobin, Hematocrit, & RBC), WBC, Reticulocytes, Platelet Function, CRP, Neutrophil Function, Bone Marrow, & DPG], End User (& Clinical Testing Labs, Research Institute, & Hospital) - Global Forecasts to 2019
Emerging markets such as China, India, Brazil, and Mexico are the new revenue pockets for companies that are engaged in the development and marketing of hematology analyzers and reagents. Growing patient population, rising healthcare expenditure, and rising trends of medical tourism owing to low-cost treatments are the key factors propelling demand for hematology tests in these emerging nations.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Clinical Microbiology Market by Product (Instrument (Incubators), Analyzer (Microscope), Reagent, Kits, Media], Disease Area (Respiratory, Gastrointestinal, STD, UTI), End User (Hospitals, Diagnostic Center, Research Institutes) - Global Forecast to 2030
The global clinical microbiology market, valued at US$5.08 billion in 2024, stood at US$5.33 billion in 2025 and is projected to advance at a resilient CAGR of 6.6% from 2025 to 2030, culminating in a forecasted valuation of US$7.34 billion by the end of the period. A key factor contributing to market growth is the rising technological advancements that have enabled the development of advanced microbial identification methods and improved antibiotic susceptibility testing.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Stem Cell Banking Market by Source (PSC, BMSC, ADSC, hESC, DPSC, NSC), Service Type (Sample Processing, Analysis, Collection, Storage), Application (Personalized Storage, Clinical (Autoimmune, Hematopoietic Disorders), Research) - Global Forecasts to 2023
The global stem cell banking market is projected to reach USD 9.30 Billion by 2023, at a CAGR of 8.2%. Major players in the global stem cell banking market include Cord Blood Registry (CBR) Systems (US), Cordlife Group Limited (Singapore), Cryo-Cell International (US), ViaCord (US), Cryo-Save AG (Netherlands), LifeCell International (India), StemCyte (US), Global Cord Blood Corporation (China), Smart Cells International (UK), Vita34 AG (Germany), and CryoHoldco (Mexico).
- Published: May 2018
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
